HER2 Support Group Forums - View Single Post - OBI Pharma transfers exclusive rights to develop, commercialize Dificid (fidaxomicin)

News · 10-04-2015, 11:00 PM

OBI Pharma, Inc. today announced an agreement with MSD, known as Merck in the United States and Canada, through a subsidiary transferring exclusive rights to develop and commercialize Dificid (fidaxomicin) in Taiwan to MSD.

More...

10-04-2015, 11:00 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,949	OBI Pharma transfers exclusive rights to develop, commercialize Dificid (fidaxomicin) OBI Pharma, Inc. today announced an agreement with MSD, known as Merck in the United States and Canada, through a subsidiary transferring exclusive rights to develop and commercialize Dificid (fidaxomicin) in Taiwan to MSD. More...